Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Category : Pharma & Healthcare

All logos and Images mentioned on this slide belong to their respective owners.

www.Marke...
Introduction to Report
§ Launch Date: November 30, 2013
§ Number of Pages: 306
§ Geography Coverage: Global
§ Available Fo...
About the Report
The competitive landscape of hemophilia A and B
recombinant therapy in the US and 5EU is dominated by
the...
Research Findings
§Overview of hemophilia A and B, including epidemiology,
etiology, symptoms, diagnosis, pathology and tr...
Research Findings Continues..
§Market Model Features
§An interactive excel forecast model based on primary
research interv...
Report Highlights:
§Number of Pages – 306
§Number of Tables – 127
§Number of Figures – 24
§Number of Companies Mentioned –...
Report Coverage
1. Table of Contents
2. Introduction
3. Disease Overview
4. Epidemiology
5. Disease Management
6. Competit...
Company Coverage

For more details regarding company coverage and TOC see the last slide
All logos and Images mentioned on...
Custom Research:
§ Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then le...
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://www.marketresear...
Upcoming SlideShare
Loading in …5
×

PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022

557 views

Published on

Market Research Reports, Inc. has announced the addition of “PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022” research report to their offering. Inquire about this report: http://goo.gl/gDomS2

Published in: Business, Health & Medicine
  • Be the first to comment

  • Be the first to like this

PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022

  1. 1. Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners. www.MarketResearchReports.com
  2. 2. Introduction to Report § Launch Date: November 30, 2013 § Number of Pages: 306 § Geography Coverage: Global § Available Format: PDF §Price For Single User License: USD 9,995 §Price For Site License: USD 19,990 §Price For Global User License: USD 29,985 §Delivery Time: Within 24 Hours (During Working Days) www.MarketResearchReports.com
  3. 3. About the Report The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through adulthood. However, the burden on patients and their families to maintain the prophylactic treatment schedule is high, and there is a significant unmet need for new therapies that can reduce the number of weekly prophylactic infusions and alleviate some of this treatment burden. www.MarketResearchReports.com
  4. 4. Research Findings §Overview of hemophilia A and B, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. §Annualized hemophilia A and B (including inhibitor patients) therapeutics market revenue, annual cost of therapy and treatment usage pattern data by patient segment forecast from 2012 to 2022. §Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the hemophilia therapeutics market §Pipeline analysis: The hemophilia pipeline is robust, with many late-stage candidates set to launch in the forecast period. The most promising 12 candidates in Phase III development are highlighted and profiled. §Analysis of the current and future market competition in the global hemophilia A and B markets, including insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications. www.MarketResearchReports.com
  5. 5. Research Findings Continues.. §Market Model Features §An interactive excel forecast model based on primary research interviews and surveys with KOLs and highprescribing physicians is included in this report*. This patient based model provides diagnosis rates, patient segmentation, treatment rates, annual costs of therapy , and indication-specific drug sales for the 10 year forecast period. The forecast model is robust, fully transparent, and easy to navigate. Moreover, our models support data presented in the reports and the complete methodology is outlined in the report and the model. www.MarketResearchReports.com
  6. 6. Report Highlights: §Number of Pages – 306 §Number of Tables – 127 §Number of Figures – 24 §Number of Companies Mentioned – 10 §Number of Marketed Drugs Mentioned – 7 §Pipeline Drugs Mentioned – 12 Phase III drugs; 11 Phase I/II §Companies Profiled – Baxter, Biogen Idec, Novo Nordisk, CSL Behring, Bayer, Pfizer §Markets Covered – US, France, Germany, Italy, Spain, UK, Japan, Argentina and China §Hemophilia A and B Patient Segmented by Method of Therapy – On-demand or prophylactic §Patients with Inhibitors Segmented Separately www.MarketResearchReports.com
  7. 7. Report Coverage 1. Table of Contents 2. Introduction 3. Disease Overview 4. Epidemiology 5. Disease Management 6. Competitive Assessment 7. Opportunity and Unmet Need 8. Pipeline Assessment 9. Current and Future Players 10.Market Outlook 11.Appendix For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners. www.MarketResearchReports.com
  8. 8. Company Coverage For more details regarding company coverage and TOC see the last slide All logos and Images mentioned on this slide belong to their respective owners. www.MarketResearchReports.com
  9. 9. Custom Research: § Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @ http://www.marketresearchreports.com/idea-center www.MarketResearchReports.com
  10. 10. How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: http://www.marketresearchreports.com/globaldata/phar mapoint-hemophilia-and-b-global-drug-forecast-andmarket-analysis-2022 About Market Research Reports, Inc. Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Amitava Sen Email : info@marketresearchreports.com Phone: +1 302-703-7787 (USA) +91-8762746600 (India) www.MarketResearchReports.com

×